“ASSESSMENT OF THE EFFECTIVENESS OF THE CLINICAL AND PHARMACOECONOMIC ASPECTS OF TOPAMAX IN PATIENTS WITH EPILEPSY”, ReFocus, vol. 2, no. 5, pp. 198–202, Jun. 2023, doi: 10.66073/researchfocus.v2i5.247.